LLY's explosive growth from Mounjaro and Zepbound outpaces MRK's Keytruda-led gains, despite valuation concerns.

PORTLAND, OR, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- The global anti-obesity drugs market, valued at $1,605.36 million in 2022, is projected to reach $4,439.34 million by 2032, expanding ...

Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...

Biopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

Morgans healthcare and life sciences expert Iain Wilkie explains what the movers and shakers have been doing in health and ...

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...